Institutional Ownership
Keros Therapeutics Inc
CUSIP 492327101COMKROSQ1 2026
13D / 13G Filings
53
Schedule 13D/13G on record
Beneficial Filers
21
Distinct reporting persons
Largest Stake
23.6%
Max % of class reported
Institutional Holders
146
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
53 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Tang Capital Management, LLC | 13G/A | — | — | SEC |
| 2 | Feb 17, 2026 | D. E. Shaw &Amp; Co., L.P. | 13G/A | 3.9% | 756.2K | SEC |
| 3 | Feb 17, 2026 | Madison Avenue International LP | 13G/A | 2.7% | 823.7K | SEC |
| 4 | Feb 17, 2026 | Exoduspoint Capital Management, LP | 13G/A | 0.0% | 13.4K | SEC |
| 5 | Jan 30, 2026 | The Vanguard Group | 13G/A | 5.0% | 1.53M | SEC |
| 6 | Nov 18, 2025 | Exoduspoint Capital Management, LP | 13G | 6.3% | 1.91M | SEC |
| 7 | Oct 27, 2025 | D. E. Shaw &Amp; Co., L.P. | 13G | 5.1% | 1.55M | SEC |
| 8 | Oct 22, 2025 | Tang Capital Management, LLC | 13G | 7.9% | 1.52T | SEC |
| 9 | Oct 16, 2025 | Pontifax Management 4 Gp (2015) Ltd. | 13D/A | — | — | SEC |
| 10 | Oct 15, 2025 | Adar1 Capital Management, LLC | 13D/A | — | — | SEC |
43 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Keros Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 2.41M | $26.63M |
| 2 | Nantahala Capital Management, LLC | 1.36M | $15.02M |
| 3 | Orbimed Advisors LLC | 759.2K | $8.38M |
| 4 | Qube Research & Technologies Ltd | 724.9K | $8.00M |
| 5 | Jacobs Levy Equity Management, Inc | 706.1K | $7.80M |
| 6 | Federated Hermes, Inc. | 689.2K | $7.61M |
| 7 | Geode Capital Management, LLC | 681.5K | $7.52M |
| 8 | Madison Avenue Partners, LP | 626.6K | $6.92M |
| 9 | Arrowstreet Capital, Limited Partnership | 590.2K | $6.52M |
| 10 | State Street Corp | 561.7K | $6.20M |